Bibliographic Details
| Title: |
Tumor Biomarker Association With Clinical Outcomes in Recurrent and/or Metastatic Head and Neck Squamous Cell Carcinoma (R/M HNSCC) Patients (Pts) Treated With Afatinib Versus Methotrexate (MTX): LUX-Head & Neck 1 (LHN1). |
| Authors: |
Cohen, E.1, Licitra, L.2, Burtness, B.3, Fayette, J.4, Gauler, T.5, Clement, P.M.6, Grau, J.J.7, del Campo, J.M.8, Mailliez, A.9, Haddad, R.I.10, Vermorken, J.B.11, Tahara, M.12, Guigay, J.13, Geoffrois, L.14, Merlano, M.C.15, Cong, X.J.16, Gibson, N.17, Solca, F.18, Ehrnrooth, E.19, Machiels, J.P.H.20 |
| Source: |
International Journal of Radiation Oncology, Biology, Physics. Mar2016, Vol. 94 Issue 4, p868-869. 2p. |
| Database: |
Academic Search Ultimate |
